Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
Jaime Landman, MD, Minimally Invasive Urology, Columbia University Medical Center, New York, NY, discusses kidney stone management. References and Resources Steggall MJ, Omara M. Urinary tract stones: types,…
Christine L. Lau, MD, Assistant Professor of Surgery, Department of Surgery, Division of Thoracic and Cardiovascular Surgery, University of Virginia Health System, Charlottesville, VA, discusses the statistics of…
Rasagiline 1 mg tablets slow the progression of Parkinson’s disease, according to Phase III trial data. From our partners at VerusMed VerusMed.com Sponsored by The Doctor’s Channel
Steven F. Rubin, DO, FACOFP dist. the 54th Past President (2007-2008) of the American College of Osteopathic Family Physicians (ACOFP), discusses the challenges physicians face today including Medicare…
Scott M. Strayer, MD, MPH, Assistant Professor of Family Medicine and Public Health Services, University of Virginia Health Systems, Charlottesville, VA, is the founder of PocketMed®, a company…
Scott M. Strayer, MD, MPH, Assistant Professor of Family Medicine and Public Health Services, University of Virginia Health Systems, Charlottesville, VA, discusses the abundance of resources available to…
Partnership to Fight Chronic Disease is a national coalition of patients, providers, community organizations, business and labor groups and health policy experts, committed to raising awareness of policies…
The FDA has expanded indications for methylphenidate (Concerta) extended-release tablets to include adults aged 18 to 65 with ADHD. For more information visit: FDA Sponsored by The Doctor’s…
In the Journal of the American Medical Association, a meta-analysis showed that patients of both genders with high-risk acute coronary syndromes were helped by an early, invasive treatment…
